Skip to main content
Top
Published in: European Journal of Epidemiology 2/2010

01-02-2010 | DIABETES MELLITUS

The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts

Authors: Maarit A. Laaksonen, Paul Knekt, Harri Rissanen, Tommi Härkänen, Esa Virtala, Jukka Marniemi, Arpo Aromaa, Markku Heliövaara, Antti Reunanen

Published in: European Journal of Epidemiology | Issue 2/2010

Login to get access

Abstract

Lifestyle factors predict type 2 diabetes occurrence, but their effect in high- and low-risk populations is poorly known. This study determines the prediction of low-risk lifestyle on type 2 diabetes in those with and without metabolic syndrome in a pooled sample of two representative Finnish cohorts, collected in 1978–1980 and 2000–2001. Altogether 8,627 individuals, aged 40–79 years, and free of diabetes and cardiovascular disease at baseline were included in this study. A low-risk lifestyle was defined based on body mass index, exercise, alcohol consumption, smoking, and serum vitamin D concentration. The metabolic syndrome was defined according to the International Diabetes Federation including obesity, blood pressure, serum HDL cholesterol, serum triglycerides, and fasting glucose. During a 10-year follow-up, altogether 226 type 2 diabetes cases occurred. Overweight was the strongest predictor of type 2 diabetes (population attributable fraction (PAF) = 77%, 95% confidence interval (CI): 53, 88%). Together with lack of exercise, unsatisfactory alcohol consumption, smoking, and low vitamin D concentration it explained 82% of the cases. Altogether 62% (CI: 47, 73%) of the cases were attributable to the metabolic syndrome and 92% (CI: 67, 98%) to the most unfavourable combination of its components. The metabolic syndrome did not modify the prediction of lifestyle factors but persons with normal blood pressure benefited more from positive changes in exercise, alcohol consumption, and smoking than those with elevated blood pressure (P for interaction = 0.01). In conclusion, modification of lifestyle factors apparently reduces type 2 diabetes risk, especially in persons with normal blood pressure.
Literature
1.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.CrossRefPubMed
2.
go back to reference van Dam RM. The epidemiology of lifestyle and risk for type 2 diabetes. Eur J Epidemiol. 2003;18(12):1115–25.PubMed van Dam RM. The epidemiology of lifestyle and risk for type 2 diabetes. Eur J Epidemiol. 2003;18(12):1115–25.PubMed
3.
go back to reference Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345(11):790–7.CrossRefPubMed Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345(11):790–7.CrossRefPubMed
4.
go back to reference Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Möhlig M, et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care. 2007;30(3):510–5.CrossRefPubMed Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Möhlig M, et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care. 2007;30(3):510–5.CrossRefPubMed
5.
go back to reference Mozaffarian D, Kamineni A, Carnethon M, Djoussé L, Mukamal KJ, Siskovick D. Lifestyle risk factors and new-onset diabetes mellitus in older adults. Arch Intern Med. 2009;169(8):798–807.CrossRefPubMed Mozaffarian D, Kamineni A, Carnethon M, Djoussé L, Mukamal KJ, Siskovick D. Lifestyle risk factors and new-onset diabetes mellitus in older adults. Arch Intern Med. 2009;169(8):798–807.CrossRefPubMed
6.
go back to reference Knekt P, Laaksonen M, Mattila C, Härkänen T, Marniemi J, Heliövaara M, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008;19(5):666–71.CrossRefPubMed Knekt P, Laaksonen M, Mattila C, Härkänen T, Marniemi J, Heliövaara M, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008;19(5):666–71.CrossRefPubMed
7.
go back to reference Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(3):2017–29.CrossRefPubMed Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(3):2017–29.CrossRefPubMed
8.
go back to reference Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–80.CrossRefPubMed Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–80.CrossRefPubMed
9.
go back to reference Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, Leung GM, et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care. 2007;30(6):1430–6.CrossRefPubMed Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, Leung GM, et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care. 2007;30(6):1430–6.CrossRefPubMed
10.
go back to reference Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes. 2002;51(10):3120–7.CrossRefPubMed Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes. 2002;51(10):3120–7.CrossRefPubMed
11.
go back to reference Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med. 2002;136(8):575–81.PubMed Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med. 2002;136(8):575–81.PubMed
12.
go back to reference Cameron AJ, Magliano DJ, Zimmet PZ, Welborn TA, Colagiuri S, Tonkin AM, et al. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med. 2008;264(2):177–86.CrossRefPubMed Cameron AJ, Magliano DJ, Zimmet PZ, Welborn TA, Colagiuri S, Tonkin AM, et al. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med. 2008;264(2):177–86.CrossRefPubMed
13.
go back to reference Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care. 2008;31(9):1898–904.CrossRefPubMed Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care. 2008;31(9):1898–904.CrossRefPubMed
14.
go back to reference Kanaya AM, Wassel Fyr CL, de Rekeneire N, Shorr RI, Schwartz AV, Goodpaster BH, et al. Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care. 2005;28(2):404–8.CrossRefPubMed Kanaya AM, Wassel Fyr CL, de Rekeneire N, Shorr RI, Schwartz AV, Goodpaster BH, et al. Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care. 2005;28(2):404–8.CrossRefPubMed
15.
go back to reference Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725–31.CrossRefPubMed Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725–31.CrossRefPubMed
16.
go back to reference McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care. 2003;26(3):758–63.CrossRefPubMed McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care. 2003;26(3):758–63.CrossRefPubMed
17.
go back to reference Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, et al. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed. J Intern Med. 2006;260(3):263–71.CrossRefPubMed Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, et al. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed. J Intern Med. 2006;260(3):263–71.CrossRefPubMed
18.
go back to reference Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, et al. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care. 2005;28(8):2013–8.CrossRefPubMed Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, et al. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care. 2005;28(8):2013–8.CrossRefPubMed
19.
go back to reference Narayan KM, Kanaya AM, Gregg EW. Lifestyle intervention for the prevention of type 2 diabetes mellitus: putting theory to practice. Treat Endocrinol. 2003;2(5):315–20.CrossRefPubMed Narayan KM, Kanaya AM, Gregg EW. Lifestyle intervention for the prevention of type 2 diabetes mellitus: putting theory to practice. Treat Endocrinol. 2003;2(5):315–20.CrossRefPubMed
20.
go back to reference Hu G, Lakka TA, Lakka HM, Tuomilehto J. Lifestyle management in the metabolic syndrome. Metab Syndr Relat Disord. 2006;4(4):270–86.CrossRefPubMed Hu G, Lakka TA, Lakka HM, Tuomilehto J. Lifestyle management in the metabolic syndrome. Metab Syndr Relat Disord. 2006;4(4):270–86.CrossRefPubMed
21.
go back to reference Liberopoulos EN, Tsouli S, Mikhailidis DP, Elisaf MS. Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures. Curr Drug Targets. 2006;7(2):211–28.CrossRefPubMed Liberopoulos EN, Tsouli S, Mikhailidis DP, Elisaf MS. Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures. Curr Drug Targets. 2006;7(2):211–28.CrossRefPubMed
22.
go back to reference Taslim S, Tai ES. The relevance of the metabolic syndrome. Ann Acad Med Singapore. 2009;38(1):29–33.PubMed Taslim S, Tai ES. The relevance of the metabolic syndrome. Ann Acad Med Singapore. 2009;38(1):29–33.PubMed
23.
go back to reference Aromaa A, Heliövaara M, Impivaara O, Knekt P, Maatela J. Aims, methods and study population. Part 1. In: Aromaa A, Heliövaara M, Impivaara O, Knekt P, Maatela J, editors. The execution of the Mini-Finland Health Survey (in Finnish, English summary). Helsinki and Turku: Publications of the Social Insurance Institution, Finland ML:88; 1989. Aromaa A, Heliövaara M, Impivaara O, Knekt P, Maatela J. Aims, methods and study population. Part 1. In: Aromaa A, Heliövaara M, Impivaara O, Knekt P, Maatela J, editors. The execution of the Mini-Finland Health Survey (in Finnish, English summary). Helsinki and Turku: Publications of the Social Insurance Institution, Finland ML:88; 1989.
24.
go back to reference Aromaa A, Koskinen S, editors. Health and functional capacity in Finland. Baseline results of the Health 2000 health examination survey. Helsinki: Publications of the National Public Health Institute B12; 2004. Aromaa A, Koskinen S, editors. Health and functional capacity in Finland. Baseline results of the Health 2000 health examination survey. Helsinki: Publications of the National Public Health Institute B12; 2004.
25.
go back to reference Lehtonen R, Kuusela V. Statistical efficiency of the Mini-Finland Health Survey’s sampling design. Part 5. In: Aromaa A, Heliövaara M, Impivaara O, Knekt P, Maatela J, editors. The execution of the Mini-Finland Health Survey (in Finnish, English summary). Helsinki and Turku: Publications of the Social Insurance Institution, Finland ML:65; 1986. Lehtonen R, Kuusela V. Statistical efficiency of the Mini-Finland Health Survey’s sampling design. Part 5. In: Aromaa A, Heliövaara M, Impivaara O, Knekt P, Maatela J, editors. The execution of the Mini-Finland Health Survey (in Finnish, English summary). Helsinki and Turku: Publications of the Social Insurance Institution, Finland ML:65; 1986.
26.
go back to reference Kostner GM. Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation (Letter). Clin Chem. 1976;22(5):695.PubMed Kostner GM. Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation (Letter). Clin Chem. 1976;22(5):695.PubMed
27.
go back to reference Reunanen A, Kangas T, Martikainen J, Klaukka T. Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals. Diabetes Care. 2000;23(9):1265–71.CrossRefPubMed Reunanen A, Kangas T, Martikainen J, Klaukka T. Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals. Diabetes Care. 2000;23(9):1265–71.CrossRefPubMed
28.
go back to reference World Health Organization. Diabetes mellitus: report of a WHO study group. Geneva: World Health Organization; 1985. World Health Organization. Diabetes mellitus: report of a WHO study group. Geneva: World Health Organization; 1985.
29.
go back to reference Heliövaara M, Reunanen A, Aromaa A, Knekt P, Aho K, Suhonen O. Validity of hospital discharge data in a prospective epidemiological study on stroke and myocardial infarction. Acta Med Scand. 1984;216(3):309–15.PubMed Heliövaara M, Reunanen A, Aromaa A, Knekt P, Aho K, Suhonen O. Validity of hospital discharge data in a prospective epidemiological study on stroke and myocardial infarction. Acta Med Scand. 1984;216(3):309–15.PubMed
30.
go back to reference Reunanen A, Aromaa A, Pyörälä K, Punsar S, Maatela J, Knekt P. The Social Insurance Institution’s coronary heart disease study. Baseline data and 5-year mortality experience. Acta Med Scand Suppl. 1983;673:1–120.PubMed Reunanen A, Aromaa A, Pyörälä K, Punsar S, Maatela J, Knekt P. The Social Insurance Institution’s coronary heart disease study. Baseline data and 5-year mortality experience. Acta Med Scand Suppl. 1983;673:1–120.PubMed
31.
go back to reference Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187–220. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187–220.
32.
go back to reference Friedman M. Piecewise constant hazards models for survival data with covariates. Ann Statist. 1982;10(1):101–13.CrossRef Friedman M. Piecewise constant hazards models for survival data with covariates. Ann Statist. 1982;10(1):101–13.CrossRef
33.
go back to reference Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res. 2001;10(3):195–216.CrossRefPubMed Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res. 2001;10(3):195–216.CrossRefPubMed
34.
go back to reference Laaksonen M, Härkänen T, Knekt P, Virtala E, Oja H. Estimation of population attributable fraction (PAF) for disease occurrence in a cohort study design. Stat Med (in press). Laaksonen M, Härkänen T, Knekt P, Virtala E, Oja H. Estimation of population attributable fraction (PAF) for disease occurrence in a cohort study design. Stat Med (in press).
35.
go back to reference Knekt P, Ritz J, Pereira MA, O’Reilly EJ, Augustsson K, Fraser GE, et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr. 2004;80(6):1508–20.PubMed Knekt P, Ritz J, Pereira MA, O’Reilly EJ, Augustsson K, Fraser GE, et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr. 2004;80(6):1508–20.PubMed
36.
37.
go back to reference Stram DO. Meta-analysis of published data using a linear mixed-effects model. Biometrics. 1996;52(2):536–44.CrossRefPubMed Stram DO. Meta-analysis of published data using a linear mixed-effects model. Biometrics. 1996;52(2):536–44.CrossRefPubMed
38.
go back to reference Schulze MB, Hu FB. Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health. 2005;26:445–67.CrossRefPubMed Schulze MB, Hu FB. Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health. 2005;26:445–67.CrossRefPubMed
39.
go back to reference Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.CrossRefPubMed Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.CrossRefPubMed
40.
go back to reference Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142(8):611–9.PubMed Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142(8):611–9.PubMed
41.
go back to reference Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med. 2007;24(5):451–63.CrossRefPubMed Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med. 2007;24(5):451–63.CrossRefPubMed
Metadata
Title
The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts
Authors
Maarit A. Laaksonen
Paul Knekt
Harri Rissanen
Tommi Härkänen
Esa Virtala
Jukka Marniemi
Arpo Aromaa
Markku Heliövaara
Antti Reunanen
Publication date
01-02-2010
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 2/2010
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-009-9405-0

Other articles of this Issue 2/2010

European Journal of Epidemiology 2/2010 Go to the issue